Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid is a synthetic small molecule and an iodinated analog of the nonsteroidal anti-inflammatory drug suprofen. It acts as a potent inhibitor of prostaglandin G/H synthase 1 (also known as cyclooxygenase 1 or COX1), the enzyme responsible for converting arachidonic acid to prostaglandins, which are mediators of inflammation and pain. The compound has been studied primarily as an experimental probe in structural biology and drug discovery, particularly for its binding interactions with COX1. It is not approved for clinical use and remains an experimental agent[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on p-(2'-iodo-5'-thenoyl)hydrotropic acid.